
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
At Prevail Therapeutics, we are developing novel gene therapies that target the root genetic causes of Parkinsons disease and other neurodegenerative disorders. Our mission is to translate recent advances in human genetics and gene therapy technology into medicines that slow or stop the neurodegenerative process. Our programs utilize a precision medicine approach targeting patient populations with urgent unmet needs, where there are currently no available therapies that modify the progressive course of their disorders. Prevail was formed in 2017 and we are building a team of dedicated, creative and talented individuals who share our passion for serving patients with neurodegenerative...
'biotechnology,pharmaceuticals,drug development,cmc,regulatory,clinical,discovery,gene therapy,parkinson''s disease,and neurodegenerative diseases'
Prevail therapeutics operates in the Biotechnology industry.
Prevail therapeutics's revenue is 11m - 100m
Prevail therapeutics has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.